These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 12784349

  • 21. Monitoring of serum squamous cell carcinoma antigen levels in invasive cervical cancer: is it cost-effective?
    Chan YM, Ng TY, Ngan HY, Wong LC.
    Gynecol Oncol; 2002 Jan; 84(1):7-11. PubMed ID: 11748969
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Clinical significance of serum squamous cell carcinoma antigen in the diagnosis, treatment and prognosis of cervical squamous cell carcinoma].
    Luan XM, Zhang Y, Wang SZ, Wang N, Li W, Zhang Q, Wei H, Zhang SL.
    Zhonghua Yi Xue Za Zhi; 2012 May 22; 92(19):1330-3. PubMed ID: 22883121
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Cancer of the uterine cervix: clinical value of squamous cell carcinoma antigen (SCC) measurements.
    Lozza L, Merola M, Fontanelli R, Stefanon B, Seregni E, Bombardieri E, De Palo G.
    Anticancer Res; 1997 May 22; 17(1B):525-9. PubMed ID: 9066575
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Squamous cell carcinoma-antigen messenger RNA level in peripheral blood predicts recurrence after resection in patients with esophageal squamous cell carcinoma.
    Honma H, Kanda T, Ito H, Wakai T, Nakagawa S, Ohashi M, Koyama Y, Valera VA, Akazawa K, Hatakeyama K.
    Surgery; 2006 May 22; 139(5):678-85. PubMed ID: 16701102
    [Abstract] [Full Text] [Related]

  • 29. [Risk factors and prognosis of node-positive cervical carcinoma].
    Feng SY, Zhang YN, Liu JG.
    Ai Zheng; 2005 Oct 22; 24(10):1261-6. PubMed ID: 16219145
    [Abstract] [Full Text] [Related]

  • 30. The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: a review of the literature.
    Gadducci A, Tana R, Cosio S, Genazzani AR.
    Crit Rev Oncol Hematol; 2008 Apr 22; 66(1):10-20. PubMed ID: 17964182
    [Abstract] [Full Text] [Related]

  • 31. SCC-Ag, lymph node metastases and sentinel node procedure in early stage squamous cell cervical cancer.
    van de Lande J, Davelaar EM, von Mensdorff-Pouilly S, Water TJ, Berkhof J, van Baal WM, Kenemans P, Verheijen RH.
    Gynecol Oncol; 2009 Jan 22; 112(1):119-25. PubMed ID: 19007978
    [Abstract] [Full Text] [Related]

  • 32. The value of squamous cell carcinoma antigen as a predictor of nodal metastasis in cervical cancer.
    Takeshima N, Hirai Y, Katase K, Yano K, Yamauchi K, Hasumi K.
    Gynecol Oncol; 1998 Mar 22; 68(3):263-6. PubMed ID: 9570978
    [Abstract] [Full Text] [Related]

  • 33. Frequency and characteristics of isolated para-aortic lymph node recurrence in patients with uterine cervical carcinoma in Japan: a multi-institutional study.
    Niibe Y, Kazumoto T, Toita T, Yamazaki H, Higuchi K, Ii N, Suzuki K, Uno T, Tokumaru S, Takayama M, Sekiguchi K, Matsumoto Y, Michimoto K, Oguchi M, Hayakawa K.
    Gynecol Oncol; 2006 Nov 22; 103(2):435-8. PubMed ID: 16677691
    [Abstract] [Full Text] [Related]

  • 34. [Determination of the SCC antigen in the serum of patients with cervical cancer].
    Crombach G, Würz H, Bolte A.
    Geburtshilfe Frauenheilkd; 1987 Jul 22; 47(7):439-45. PubMed ID: 3623046
    [Abstract] [Full Text] [Related]

  • 35. The prognostic value of TPA and SCC in squamous cell carcinoma of the cervix.
    Ngan HY, Cheng GT, Yeung WS, Wong LC, Ma HK.
    Gynecol Oncol; 1994 Jan 22; 52(1):63-8. PubMed ID: 8307503
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Relationship between squamous cell carcinoma antigen levels and tumor volumes in patients with cervical carcinomas undergoing neoadjuvant chemotherapy.
    Kim BG, Kim JH, Park SY, Lee JH, Lee ED, Lee KH, Park KB, Lee BH, Kim KH.
    Gynecol Oncol; 1996 Oct 22; 63(1):105-13. PubMed ID: 8898178
    [Abstract] [Full Text] [Related]

  • 38. Prognostic significance of squamous cell carcinoma (SCC) antigen in primary advanced and recurrent cervical carcinoma.
    Meier W, Stieber P, Hasholzner U, Baumgartner L, Fateh-Moghadam A.
    Anticancer Res; 1997 Oct 22; 17(4B):2959-62. PubMed ID: 9329575
    [Abstract] [Full Text] [Related]

  • 39. Clinical usage of the squamous cell carcinoma antigen in patients with penile cancer.
    Touloupidis S, Zisimopoulos A, Giannakopoulos S, Papatsoris AG, Kalaitzis C, Thanos A.
    Int J Urol; 2007 Feb 22; 14(2):174-6. PubMed ID: 17302580
    [Abstract] [Full Text] [Related]

  • 40. Serum soluble interleukin-2 receptor (sIL-2R) assay in cervical and endometrial cancer. Preliminary data.
    Ferdeghini M, Gadducci A, Prontera C, Marrai R, Malagnino G, Annicchiarico C, Fioretti P, Bianchi R.
    Anticancer Res; 1993 Feb 22; 13(3):709-13. PubMed ID: 8317901
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.